In 2014, the Commission fined French pharmaceutical company Servier and 5 other producers of generic medicines almost 430 million for concluding a series of deals to protect Servier's bestselling blood pressure medicine, perindopril, from price competition from other generics in the EU.

Please remove spaces between words.
In2014,theCommissionfinedFrenchpharmaceuticalcompanyServierand5otherproducersofgenericmedicinesalmost430millionforconcludingaseriesofdealstoprotectServier'sbestsellingbloodpressuremedicine,perindopril,frompricecompetitionfromothergenericsintheEU.